NIAGEN BIOSCIENCE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
NIAGEN BIOSCIENCE, INC. (NAGE) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period of 0 shares for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-10.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod · last filed 2020-03-10
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2012-12-29 was -500.00K shares.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2012-09-29 was -10.00K shares.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2019 was 0.00 shares, a 100.00% decline from fiscal 2018.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2018 was 2.00 shares.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2012 was -1.14M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 12 month |
|---|---|---|---|---|---|
| 2019-12-31 | 0.00 shares 10-K · filed 2020-03-10 | ||||
| 2018-12-31 | 2.00 shares 10-K · filed 2020-03-10 | ||||
| 2015-05-13 | 10.00K shares 10-Q · filed 2015-05-14 | ||||
| 2012-12-29 | -500.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | -510.00K shares derived: sum of 2 quarters · filed 2013-03-29 | -1.14M shares 10-K · filed 2013-03-29 | ||
| 2012-09-29 | -10.00K shares derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-08 | -640.00K shares 10-Q · filed 2012-11-08 | |||
| 2012-06-30 | -630.00K shares 10-Q/A · filed 2012-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |